Ultrasound-Guided Botulinum Toxin Injection with Factor VIII Administration for Post Stroke Spasticity in a Hemophilia A Patient
Brain & Neurorehabilitation
;
: e20-2018.
Artículo
en Inglés
| WPRIM
| ID: wpr-716991
ABSTRACT
Chemodenervation with botulinum toxin (BTX) has been recommended for focal spasticity. BTX injection should be performed with caution in patients with bleeding disorders and/or receiving anticoagulation therapy. We present a case of BTX injection for post-stroke spasticity in a patient with hemophilia A who could not take oral spasmolytics due to chronic hepatitis C. To minimize the bleeding risk, we replaced factor VIII intravenously in accordance with the World Federation of Hemophilia guidelines for minor surgery. FVIII (3,000 IU) was administered 15 minutes before BTX injection. One day later, 2,000 IU was administered, and 2 days later, another 2,000 IU was administered. We performed the real-time Ultrasound-guided BTX injection three times, then spasticity and upper extremity function improved without adverse events. BTX injection can be considered as a treatment option for spasticity among patients with hemophilia.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Parasimpatolíticos
/
Procedimientos Quirúrgicos Menores
/
Toxinas Botulínicas
/
Factor VIII
/
Ultrasonografía
/
Hepatitis C Crónica
/
Accidente Cerebrovascular
/
Extremidad Superior
/
Hemofilia A
/
Hemorragia
Tipo de estudio:
Estudio diagnóstico
/
Guía de Práctica Clínica
Límite:
Humanos
Idioma:
Inglés
Revista:
Brain & Neurorehabilitation
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS